Fractional CIPO for Funded & Pre-Revenue Companies
Every dollar you spend on IP is a dollar you did not spend on product, marketing, or revenue.
That trade-off is real. Investors expect IP. Competitors are filing. Your attorney is ready to draft. But the harder questions rarely get the time they deserve. Should you file this patent at all? Does it protect something customers will pay for? Can you detect infringement? Will a competitor design around it in an afternoon?
At this stage, patent spend is capital allocation. I bring structure, framework, and data to those decisions so your board can allocate IP capital with the same rigor they apply to everything else.
A fractional Chief IP Officer gives you that framework.
What Changes When This Role Exists
Filing decisions become structured and rational
Every invention gets a clear recommendation: invest, defer, or pass. The rationale is written down and tied to your strategy. Your board can see why each decision was made and have confidence in it. Over time, your engineers learn what makes a patent enforceable. The inventions get better.
The patents you file are built for deployment
Every approved invention gets a prosecution playbook before counsel writes a single claim. Targeted infringers. Claim architecture. Continuation strategy. Counsel drafts to a specification instead of guessing.
Bad filings get stopped early
A granted patent that cannot be enforced is the most expensive outcome in patent law. You paid for everything and got nothing. A structured evaluation catches these before money is spent.
Your board sees the IP position in business terms
Spending tracked against budget. A written rationale for every filing. When an investor asks about your IP, the answer is ready, confident, and grounded in data.
Timing becomes a strategic decision
Filing too early is one of the biggest mistakes at this stage. Edison did not patent the light bulb. Twenty people had light bulb patents before him. His patent was on the filament, the last piece that made it work. Sometimes the right answer is to defer, document the invention, and file when the data supports it.
Your first patent is usually your least valuable. Technology and market risks are highest at that point. Subsequent patents, filed when you have traction and market feedback, are more likely to align with actual commercial value.
The job is to make sure you do not burn your limited budget on the early ones that do not matter, and that you are positioned to file the later ones that do.
The Mistakes We See
These patterns destroy patent value at pre-revenue companies. Every one comes from making filing decisions based on enthusiasm or habit instead of structured analysis.
Patenting the vision instead of the invention
The entrepreneur has a big idea. The attorney files a patent on the concept. But patents protect specific technical solutions, not visions. Filing before you have data produces patents that do not hold up in court.
Filing a provisional to “save money”
A provisional delays your patent by up to a year. Its only real benefit is extending the term at year 20, which matters to Big Pharma, not startups. Startups need patents fast. The Patent Prosecution Highway can issue a patent in 9 to 12 months. A provisional pushes that back a full year, doubles the billing, and creates a false sense of progress. If the invention is not ready, do not file anything.
Undetectable infringement
You patented a server-side algorithm behind a competitor’s firewall. You will never know if they infringe. That patent should have been a trade secret. Instead, you published your approach for competitors to read.
Claims that target the wrong actor
Your patent describes steps performed by the end user, not the competitor who sells the product. A heat-moldable shoe insert where the claims describe the consumer heating it and inserting it? The infringer is your customer.
Trivial design-arounds
A competitor changes one element and walks around your claims. Patents only have value when they cover the way competitors must solve the problem. One approach among several equivalent options is a patent on nothing.
No business alignment
The patent covers a feature no customer cares about. Apple’s slide-to-unlock patent was technically trivial but addressed a real customer problem. Technical sophistication is not business value.
Anchoring to an early filing date
Every patent in a family expires 20 years from the earliest filing date. Companies that file early and disclose broadly are locked into a declining timeline. When the company finally hits traction, the patents are expiring.
The Engagement
I start with the business. Products, revenue model, customers, competitors, growth plans. The portfolio gets evaluated against the company as it operates and within its competitive environment. After 90 days, leadership has a clear view of which assets matter, a framework for evaluating new inventions, playbooks for active filings, and a board-ready IP position.
Phase 2 is a standing function. Invention review as new ideas surface. Prosecution oversight. Outside counsel direction. Periodic strategy calls covering the business and how IP fits.
Common Questions
We only have budget for a few patents. Is this worth it?
That is exactly when it matters most. When every patent competes with product development for the same dollar, each filing decision carries more weight.
What if our attorney says we should file?
Filing more patents is more work for them. That is not just a conflict of interest; it is a structural incentive. I provide the business analysis your attorney is not positioned to give.
How does this work with my existing patent attorney?
They keep drafting and prosecuting, but with clear direction and fast decisions. It becomes a working partnership.
What if we are not ready to file yet?
Good. That means the evaluation is working. The invention gets documented. When the technology matures, you file from a position of knowledge instead of urgency.
Why does IP need board-level attention at this stage?
Patent decisions have 20-year consequences. They affect your next fundraise, your competitive positioning, and your exit. At this stage, every dollar on IP is a dollar that did not go to building the product.
